Skip to main content
Top

The Chinese-German Journal of Clinical Oncology

Issue 4/2008

Content (15 Articles)

Clinical study of docetaxel-vinorelbine as second-line chemotherapy in advanced non-small cell lung cancer

Jun Guo, Weiping Li, Degang Song, Zhehai Wang, Jie Liu, Changzheng Li, Zhen Chen, Huan Shi

The clinical evaluation of Iressa first-line treatment of senium advanced-stage non-small cell lung cancer

Xiuhua Sun, Yang Zhang, Xian Zhang, Jing Yu, Yinghua Li, Xiaoyan Yang, Zhaoxia Dai, Man Li

Expressions of FEZ1 and Survivin, and their significance in small cell lung cancer and squamous cell lung carcinoma

Gang Chen, Xiaoling Wang, Yueping Liu, Lining Wang, Huichai Yang, Huijun Duan

Effect of matrine on HepG2 cells: role of glutathione and cytochrome c

Xiangdong Cheng, Yian Du, Ling Huang, Zhiming Jing, Zhiguo Zheng

Decreasing activity of NF-κB inhibits the proliferation of A549 cells via the down-regulation of cyclin D1 expression

Jian Zhang, Yongjian Xu, Weining Xiong, Zhenxiang Zhang, Chunling Du, Lifen Qiao, Wang Ni, Shixin Chen

Bone marrow-originated endothelial progenitor cells contribute to neovasculature of tumor

Yizhou Luo, Xi Wang, Ziheng Guo, Guanzheng Yu, Jiejun Wang

Investigation of bystander effect in Molt-4 cells induced by ultraviolet ray

Dan Huang, Tian Xiao, Xiangshang Xu, Deding Tao, Junbo Hu, Jianping Gong

Effect of cell cycle and radiosensitivity by CoCl2 induced hypoxia in Eca109 cells

Hongzhen Zhang, Huige Fan, Ning Xu, Xinbo Duan, Bin Liu

Application of stilamin on advanced gastrointestinal carcinoma patients complicated with malignant bowel obstruction

Jundong Wu, Yezhong Zhuang, Wenhe Huang, Miansheng Huang, Weifeng Wang, Muming Xu

Hypermethylation of promoter 5′CpG island of p16 gene in glioma tissue and plasma

Chengdong Wang, Lili Wu, Lixue Guan, Daokui Wang, Yuting Wang, Zhe Wang

MRI investigation for low-grade glioma after gamma knife radiosurgery

Yihong Guo, Xibiao Wu, Yinhui Den, Zhongjun Hou, Yaotang Chen, Xi Li

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine